RVP

Drug Catalog - Product Detail

TRIAMCINOLONE ACET CREAM USP CRM 0.001 80GM

NDC Mfr Size Str Form
00603-7862-90 PAR PHARMACEUTICALS 80 0.1% NA
Product Image

PACKAGE FILES

Package Image
Package Image
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include triamcinolone acetonide. Triamcinolone acetonide is designated chemically as 9-Fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. Graphic formula: Each gram of 0.1% triamcinolone acetonide cream provides 1 mg of triamcinolone acetonide, respectively, in a cream base containing cetyl alcohol, isopropyl palmitate, methyl paraben, mineral oil/lanolin alcohol, polysorbate 40, propyl paraben, propylene glycol, propylene glycol monostearate, purified water, sorbic acid, sorbitan monopalmitate, stearyl alcohol and xanthan gum. Triamicinolone formula
How Supplied
HOW SUPPLIED Triamcinolone Acetonide Cream, USP 0.1% is supplied in tubes containing 80 g (NDC 0603-7862-90).
Indications & Usage
INDICATIONS AND USAGE Triamcinolone acetonide cream 0.025% and 0.1% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Dosage and Administration
Dosage and Administration Apply the 0.1% triamcinolone acetonide cream to the affected area two to three times daily. Rub in gently. Occlusive Dressing Technique Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Gently rub a small amount of cream into the lesion until it disappears. Reapply the preparation leaving a thin coating on the lesion, cover with a pliable nonporous film, and seal the edges. If needed, additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply triamcinolone acetonide cream under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional cream should be applied, without occlusion, during the day. Reapplication is essential at each dressing change. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.